Pro Medicus Limited

So I think there will be selling pressure just a little bit further up from here.

Okay, a particular favourite of mine is Pro Medicus.

The bounce back's almost as impressive, but it's got a bit further to go to make back to some levels where it's been earlier.

But let's have a look at the Pro Medicus chart and get your thoughts on that.

Yeah, look, it's had a pretty good bounce recently.

It's coming close to a couple of previous little peaks there, and it is looking a bit sort of overboard on the technicals.

Although I had a conversation with the gentleman Cameron Kirko from Pitcher Partners, and he reckons, well, I don't want to give it all away, but he did weigh in on Technology One.

Pro Medicus, Next DC.

You can find that interview online, ausbiz.com.au, if you haven't already.

REITs in focus and really interesting to see some of these taking a big leg higher.

Fleet Partners Group entered the top 30 momentum list 33 sessions ago.

In eighth place, PME, Pro Medicus, with a 10% gain this week and a 22% increase this quarter.

Pro Medicus entered the top 30 momentum list four sessions ago and entered the launch pad 12 sessions ago, returning 18% since hitting the launch pad.

In seventh place,

MSV, Mitchell Services, with a 29% gain this quarter.

It's the long term.

So if we have a look at some of the best performers for the year, Pro Medicus at the top, up 52%.

Great pick.

Great.

It was transformational.

One of your favourite examples, mate, Pro Medicus.

They bought the software.

They were an entirely different company.

It's just that why would the market react so much to one, in an isolation, not awful, not great news, but not like existential or anything like this.

But how often do we see this? We saw that with CSL not too long ago or Xero or ProMedicus or name high-flying sort of tech stock.

It's the phenomenon that you must be aware of when buying a company that, the term is the one we use a lot and it's a great one, which is price for perfection.

Because- People are right to kind of go, well, it's not great news, but why 40%? And it's like, that's what you expose yourself to when there is so much in the price.

Claude's top three picks were Xero, James Hardy and 4D Medical.

And Gemini's top three picks were ProMedicus, WiseTech and TechOne.

So there's a little bit of overlap there.

Let's just get straight into it because there's a lot of stocks on that list.

It's not going to be profitable for some years.

And great products, got a great sales pipeline.

It's got ProMedicus on the register.

A lot of things to like with this business.

I think even if you were a doctor, given that this is actually an AI product, it would be hard to understand that to that level.

This sort of looks like almost an early Pro Medicus, I guess.

And you can see the success that that business has had.

Once you can build something in that space that is highly valuable to clinicians.

And we're seeing broadly with the software sector overall, and we might touch on some of the other names.

Now, we started to see them bottom and in some cases recover like Pro Medicus, Technology One, but even the ones that have been laggards, even, you know.

They've started to sort of form a steady base and haven't really been getting sold off in recent weeks, despite other parts of the market coming under pressure.

So yeah, we think Pro Medicus is worth adding to.

It's a top five holding in our managed fund.

It's kind of a real blue chip tech stock.